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Abstract
Objective. – To review the published information on physical training for fibromyalgia (FM) and related syndromes.
Methods. – A search of Medline literature (via Ovid and PubMed) with the following keywords: FM, chronic fatigue syndrome, therapy,
rehabilitation, aerobic, exercise, and cognitive behavioral therapy. The reference lists of articles were examined for additional related articles.
Results. – Several studies investigated the benefits of graded exercise therapy for patients with FM or related syndromes. Although some
systematic reviews have not established an unequivocal benefit of physical training, most authors report a benefit for patients with chronic pain or
fatigue. Ideally, such a therapy should be a part of multidisciplinary program. Muscular rehabilitation is reserved for preventing the decondition-
ing syndrome often reported in patients and the vicious cycle of pain, avoidance and inactivity behaviors, or even kinesiophobia, deconditioning,
incapacity and psychological distress.
Conclusion. – This review emphasizes the relevance of graded physical training for treating FM and related syndromes. The development of
rehabilitation centers, with experts able to propose a relevant therapy to patients with chronic pain or fatigue, should help alleviate this public
health problem.
© 2007 Elsevier Masson SAS. All rights reserved.
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1. Introduction
Fibromyalgia (FM) is defined as a chronic and diffuse poly-
algic syndrome characterized by musculoskeletal pain (axially
distributed, including pain on both left and right sides of the
body and pain above and below the waist) for more than
3 months [93]. This syndrome is associated with a widespread
state of allodynia, abnormal manifestations of nociception,
defined as pain perception resulting from a stimulus that nor-
mally should not induce a painful response [38]. Patients with
FM usually have additional complaints such as pronounced
fatigue, sleep disturbances, psychological distress, articular
pain, muscular spasms and morning stiffness [91]. The co-
existence of FM with other non-musculoskeletal affections,
such as genitourinary disorders, irritable bowel syndrome or
restless leg syndrome, are frequent [28,72,74,82,85,91,94].
FM in the general population has relatively high prevalence.
The syndrome represents a major public health problem
because of the increased need for health care and the high
rate of work absenteeism (sometimes longer than 1 year) [41,
42,50]. In 1981, Yunus et al. [96] reported that 20% of patients
consulting a rheumatologist for the first time presented with
FM syndrome, making it the most common diagnosis after
rheumatoid arthritis [12,23]. In 1995, Wolfe et al. [92], in a
study of 3000 subjects, reported a prevalence of 2% in the
North American adult population. The mean was 3.4% for
females and 0.6% for males. A more recent study [87] revealed
3.3% of subjects had FM (4.9% females vs. 1.6% males), with
an increased rate in women 50–64 years old (8.9%). A sex
ratio analysis finds that 90% of FM patients are women [92].
Afibromyalgia diagnosis has been reported in children [95].
Low socioeconomic level, heavy physical work, low educa-
tional level or divorced status are some of the factors related
to FM [87]. The psycho-socio-cultural aspect probably plays a
part in the life and “exteriorization” of chronic pain [5].
Therapists frequently treat patients with chronic pain or fati-
gue, one of these symptoms sometimes predominating over the
other. The diagnosis of FM is made only after the exclusion of
objective diseases (rheumatic, systemic, endocrine disorders,
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anomaly of calcic metabolism, underlying neoplasia) [90,94].
Investigations must exclude metabolic, toxic or inflammatory
myalgia, among others [90,94]. FM represents a syndrome
consisting of a group of symptoms likely to constitute a parti-
cular nosologic entity. The syndrome has at its boundaries
other entities with no systematically explained etiology such
as spasmophily [3] and chronic fatigue syndrome (CFS) [24,
36]. About 70% of CFS patients display symptomatic signs
of FM, whereas 42% of FM patients meet CFS criteria [8,9,
29–31,55,63] and 37% of CFS subjects meet FM criteria
[15]. Wessely et al. [86] suggested that CFS, FM and irritable
bowel syndrome are polymorph expressions of the same
somatic and psychological disorder.
2. Materials and methods
We conducted a Medline search (via OVID and PubMed)
for articles on FM. Keywords included FM, CFS, therapy,
rehabilitation, aerobic, exercise, and cognitive behavioral ther-
apy. The reference list of articles were examined for additional
related studies.
3. Therapy and benefits of reconditioning programs
The pathophysiology of FM remains unknown. Several
hypothesis have suggested muscular anomalies, sleep, neuroen-
docrinal, psychological, immunological, and central nervous
system disorders, although none has been clearly demon-
strated. In fact, such changes could represent symptoms sec-
ondary to the FM syndrome.
Although the pathophysiology of FM is still unclear, rigor-
ous clinical assessment and the establishment of therapeutic
objectives represent essential preconditions to determine the
best therapeutic option [79]. Would the patient accept persis-
tent pain? Which kind of activity is preferred? How can the
quality of life and functional capacity be improved? Educating
patients appears necessary to avoid drug over-consumption [2].
Several cognitive factors, such as patients’ beliefs related to
the interpretation of their chronic pain status, can play an
essential role in the expression of symptoms. These erroneous
beliefs—dramatization, untreatable affection, avoidance beha-
vior—represent obstacles to a “reactivation” program. Smith
et al. [73] showed that cognitive distortion related to pain
was associated with incapacity. Consequently, the medical
care of FM patients requires a multidisciplinary approach
including information, education, medical follow-up,
cognitive-behavior strategies, and exercise therapy, the latter
being a key component in the therapy.
Because pharmacological therapy does not provide evident
benefits to FM patients, nonpharmacological therapy is essen-
tial [50]. The influence of some molecules has been investi-
gated in randomized controlled studies, but results appear to
be conflicting.
Tricyclic antidepressants have various effects through their
action on serotonin systems [56]. Amitriptyline (10–25 mg/day)
appears effective to improve the quality of sleep and pain
intensity in FM, although fatigue is better improved with
cyclobenzaprine (10–30 mg), which has a major myorelaxant
effect [13,45]. Decreased pain resulting from antidepressant
medications does not seem to be related to the antidepressive
action, because no difference was observed on treatment of
patients with or without depression [60]. The positive effect
of such therapy is decreased over time, thus reducing its rele-
vance. Moreover, adverse effects resulted from anticholinergic
actions [17]. The selective serotonin reuptake inhibitors (fluox-
etin, citalopram) result in nonsignificant pain decrease. How-
ever, sleep disturbances, depression and mood can be improved
[2,17]. A nonselective serotonin reuptake inhibitor (venlafaxin)
decreased symptoms, including fatigue, in 55% of FM patients
with an associated psychiatric disorder (depression and anxi-
ety) [2,22]. Some studies reported a benefit of benzodiazepines
in treating specific symptoms (anxiety, myorelaxant effect and
pain). However, such drugs can result in physical dependence
and should therefore be used with caution. A double-blind ran-
domized study revealed that alprazolam (0.5–3 mg/day for a
short period) was effective [68]. Nonsteroidal inflammatory
drugs do not seem to be effective and can only play a co-
antalgic action in FM treatment [2,68]. The association of ibu-
profen and alprazolam appears more efficacious than ibuprofen
alone, although additional benefits are limited [68]. Naproxen
would be better taken with amitryptilin [68]. In a recent
double-blind randomized study, Crofford et al. [18] revealed
the effectiveness of pregabalin (450 mg/day) in pain decrease
as well as fatigue and sleep improvements as compared with a
placebo group. Melatonin does not seem to improve the quality
of sleep in FM patients, despite its regulatory action on the
various cycles [62]. Ketamine, a molecule blocking the
N-methyl-D-aspartate receptors, appears effective in decreasing
pain perception [35].
Local injections of lidocain in three or four tender points [7,
49] have been shown to decrease pain intensity. The effects
could be explained by the mechanical action rather than by
the product used [37].
In association with pharmacological therapy, which pro-
vides symptomatic action, physical training appears clearly
indicated in the FM syndrome. Several studies, most often ran-
domized controlled trials, investigated the benefit of graded
exercise therapy, alone or included in a multidisciplinary pro-
gram. In 1989, Bennett et al. [6] reported that 80% of FM sub-
jects had an abnormally low cardiovascular fitness. As a result,
several studies investigated the benefits of a rehabilitation pro-
gram. McCain et al. [51] reported the benefits of a cardiovas-
cular program. The authors observed an increase in pain
threshold, as well as improvements in quality of life and cardi-
ovascular fitness but no difference in pain intensity or sleep
disturbances. In a Mengshoel et al. [53] study, subjects
attended biweekly sessions of aerobic dance for 20 weeks,
with only improved static endurance of upper limbs as com-
pared with the control group.
Martin et al. [48] conducted a 6-week program (three ses-
sions per week) of aerobic strength and stretching exercises.
Significant improvement was seen in pain, endurance and ten-
der point count. Nichols and Glenn [58], with a small sample,
tested an 8-week program of walking, with only significant
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improvement in the positive symptom total subscale of the
Brief Symptom Inventory. Valim et al. [80] examined the
effect of a 20-week aerobic program of sessions attended
three times a week and found improvements in maximal oxy-
gen consumption, anaerobic threshold, pain intensity, mental
status and emotional distress. Gowans et al. [34] reported posi-
tive changes in physical fitness as well as reduction of mental
health problems and somatic symptoms 1 year after completion
of a 23-week program of aerobic exercises. Da Costa et al. [19]
observed functional improvement and pain decrease in patients
attending a home exercise program for 12 weeks. However,
according to Dobkin et al. [21], a supervised program results
in additional benefits because of the lower long-term adherence
observed in a home program. Tiidus et al. [76], as well as
Dawson et al. [20], studied the benefits of physical training
programs (including aerobic, strength and flexibility exercises).
Mood, tender point count and walking speed improved but not
work capacity or flexibility. Rooks et al. [67] observed an
increase in strength, 6-min walk distance and scores on the
Fibromyalgia Impact Questionnaire (FIQ) after a 20-week pro-
gram of strength and fitness exercises. The authors also
reported that such a program was well tolerated by FM patients
with high adherence. McCain et al. [51] compared patients
undergoing aerobic exercises for 20 weeks with a group attend-
ing flexibility sessions and found improvements in physical
function and pain threshold scores in the former group but no
difference in pain intensity or sleep disturbances. White and
Nielson [88] randomized subjects to usual care, stress manage-
ment training or aerobic exercise. The latter program led to
benefits in function, work capacity and pain (intensity and dis-
tribution). Martin et al. [48] randomized patients to a program
of aerobic and flexibility exercises or relaxation, with more
benefits seen in patients attending the aerobic and flexibility
program. Verstappen et al. [84] also reported improvement in
physical function of FM patients following a physical training
program.
Other works assessed the efficacy of physical training in an
inpatient multidisciplinary approach. Nielson et al. [59] inves-
tigated patients attending a 3-week program (EMG biofeed-
back relaxation, aerobic exercises, stretching, cognitive-
behavioral therapy, family education, and pacing and enhance-
ment of pain tolerance) and observed decreased pain and
improvements in pain control, emotional distress and func-
tional ability. These benefits were maintained at 30-month
follow-up [88]. Turk et al. [79] evaluated a multimodal treat-
ment program combining education, exercise therapy and func-
tional re-education, and cognitive-behavioral therapy. Patients
showed significant improvements in pain severity, anxiety,
depression and fatigue. Results of a study on the benefits of a
short (1.5 days) but intensive multidisciplinary outpatient pro-
gram (including cognitive behavioral therapy, physical exer-
cises and patient education) showed a significant increase in
FIQ scores [61]. Bailey et al. [1] found significant improve-
ment in physical function following a 12-week multimodal
program consisting of education and physical exercises.
Physical training has also been recommended in the treat-
ment of syndromes related to FM and appears to be a key com-
ponent in the rehabilitation program for CFS patients. A study
by Fulcher and White [25] allocated 66 CFS patients to a daily
(30 min/day) aerobic exercise program (cycling, walking or
swimming with an intensity corresponding to 60% of oxygen
maximal consumption) or to a program combining relaxation
and flexibility exercises (30 min/day, five times per week).
Subjects performing the aerobic exercise program showed sig-
nificant improvements in well-being (55% versus 27%). The
authors also underlined the benefits of exercises on fatigue
and physical function. Powell et al. [64] compared patient edu-
cation to encouraged graded exercise versus written informa-
tion (control group). At 1 year, the educational intervention
resulted in improved physical functioning, fatigue, mood,
sleep and disability as compared with written information.
Moreover, no study found harmful effects with prolonged rest
in CFS patients. However, perpetuated or increased fatigue in
healthy subjects or people recovering from viral illness has
been reported after prolonged rest [66].
4. Discussion
To suggest a treatment including a graded physical training
program can appear paradoxical in patients with continuous
pain or fatigue. Nevertheless, several studies reported that
most patients with FM are physically deconditioned [6,46].
Thus, such rehabilitation programs aim to avoid the vicious
cycle of pain, avoidance and inactivity behaviors or even kine-
siophobia, deconditioning, incapacity and psychological dis-
tress. Actually, pain, whose expression and modulation are
usually influenced by various psychological, behavioral [78]
and socioeconomical [5] factors, could lead to avoidance beha-
vior or even complete inactivity. Such a situation results in a
real deconditioning that is associated with bioenergetic
changes, perpetuated inactivity, and can explain the increase
of pain subjects feel when possibly starting physical activities
again. In consequence, the resulting professional, leisure and
home incapacity appear all the more difficult to deal with,
because it remains unexplained by somatic elements.
Several studies conducted for more than a decade underline
the benefits of physical training, although some systematic
reviews of literature [11,71,72] did not report clearly the effec-
tiveness of this therapeutic option. Such therapy can follow
some pain and disability assessments (including various physi-
cal tests, pain assessment, and several questionnaires about
quality of life, anxiety and depression), which allow for a rig-
orous longitudinal follow-up [47]. The kind and the progres-
sion of the activities recommended, and duration, frequency,
intensity of the sessions represent essential parameters in the
rehabilitation programs for FM patients [43,69].
A frequency of training reaching three sessions per week, as
recommended by the American College of Sports Medicine
(1999), appears relevant. According to several authors, attend-
ing the training sessions with a higher frequency is problematic
for FM patients [53,54,89]. The level of exercise intensity
recommended corresponds generally to an aerobic training.
Thus, it should range from 60% to 75% of the theoretical max-
imum heart rate (HR), allowing a graded progression without
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any risk of overtraining [16]. Nevertheless, the patient should
be made aware of a tolerable short-term increase in pain and
fatigue during the first sessions. McCain et al. [51] advocate a
higher level of exercise intensity (with a HR higher than
150 bpm) that induces the release of beta-endorphin [32,44,
70], growth hormone [27,39,83] or serotonin [14,26,40,51].
According to the authors, the absence of pain decrease some-
times reported in literature results from physical training with
too of a low level of exercise intensity. However, other authors
found increased pain and decreased FIQ scores with too high
of a level of exercise intensity [54,81]. The recommended exer-
cises can include various aerobic activity (walking, cycling,
stepping, rowing), as well as dynamic exercise for the upper
and the lower limbs. Relaxation and stretching exercises
allow for reducing excessive muscular tone and increasing
flexibility, respectively. A high adherence rate should be
advised.
Moreover, the exercise drop-out rate in healthy subjects
averages sometimes 50% after a 6-month training program
[43]. In a work by Wigers et al. [89] on physical training for
FM patients, the authors had to stop the study earlier than
expected because of lack of participants. Thus, despite the pre-
sence of nearby rehabilitation centers and patients motivation,
regular attendance remains difficult, especially when patients
have to carry out physical training individually [89].
Improvements in muscular performance could be explained
by various adaptations commonly observed following training
such as hypertrophy of slow-twitch fibers and increased capil-
lary and mitochondrial density and myoglobin concentration,
contributing to oxygen diffusion into the cytoplasmic compart-
ment [43,58]. Physical exercises have a positive influence on
other parameters such as the following:
● reduced anxiety and depression [16,51];
● increased pain threshold [44];
● increased tolerance to symptoms [16,44];
● released of endorphins resulting from stimulation of the
opioid system [44] when efforts exceed the aerobic thresh-
old or when they last more than 60 min [70] or with exer-
cises at a lower level of intensity, when performed by sub-
jects strongly deconditioned [32];
● improved mood, well-being and self-confidence, as well as
a decrease of helplessness feeling [33,57,65,75];
● improved quality of sleep [51,77].
Group treatment gives FM patients the opportunity to talk
and to be taken into account by health care professionals.
Cognitive-behavioral therapy, aiming to change unfavorable
behavior, to learn symptom management and coping skills
and performing physical activities, represents a relevant com-
plementary approach [4,10,52,69,79].
Physical training programs should be at least 12 weeks for
the expected benefits [10,48] and will be maintained only if
patients continue to perform physical activities. Poor results
have been observed in patients interrupting the program [33,
89], whereas the literature generally reports good outcome in
FM patients who continue performing physical activity indivi-
dually (for a short period but with sufficient frequency and
intensity) [89].
Despite a still unclear physiopathology, the diagnosis of FM
allows patients to remove the “imaginary sick” feelings and to
accept the reality of the condition. Such a realization is neces-
sary to establish a relation of trust between the therapist and the
patient. Medical care preceded by assessments of somatic, psy-
chosocial and behavioral factors is ideally realized in a multi-
disciplinary team composed of therapists who share similar
common and consistent therapeutic concepts. Therapy is often
complicated by feelings of individual inefficacy, discourage-
ment, or even aggressiveness resulting from several therapeutic
failures and frustration. The therapeutic options should encou-
rage patients to be active. Physical training represents a key
component; it aims to improve physical functions to possibly
induce a secondary pain decrease. Reconceptualizating erro-
neous belief and learning strategies (relaxation, self-coping,
realistic planning of daily activity, stress management, etc.)
will help to replace the unfavorable behavior into new more
adapted attitudes, necessary to the maintenance and the pro-
gression of the benefits [5,49,69].
5. Conclusion
This article underlines the benefits of progressive muscular
rehabilitation in the treatment of FM. The development of reha-
bilitation centers with specialized experts who could propose a
relevant therapy to such patients should contribute to the med-
ical care of this public health problem.
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